NO893105L - Acylderivater av hydroksypyrimidiner. - Google Patents

Acylderivater av hydroksypyrimidiner.

Info

Publication number
NO893105L
NO893105L NO89893105A NO893105A NO893105L NO 893105 L NO893105 L NO 893105L NO 89893105 A NO89893105 A NO 89893105A NO 893105 A NO893105 A NO 893105A NO 893105 L NO893105 L NO 893105L
Authority
NO
Norway
Prior art keywords
derivatives
acyld
hydroxypyrimidines
substituted
compounds
Prior art date
Application number
NO89893105A
Other languages
English (en)
Norwegian (no)
Other versions
NO893105D0 (no
Inventor
Frederick Judson Walker
John Lawrence Lamattina
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO893105D0 publication Critical patent/NO893105D0/no
Publication of NO893105L publication Critical patent/NO893105L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Liquid Carbonaceous Fuels (AREA)
NO89893105A 1987-12-02 1989-08-01 Acylderivater av hydroksypyrimidiner. NO893105L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/003171 WO1989005295A1 (en) 1987-12-02 1987-12-02 Acyl derivatives of hydroxypyrimidines

Publications (2)

Publication Number Publication Date
NO893105D0 NO893105D0 (no) 1989-08-01
NO893105L true NO893105L (no) 1989-09-27

Family

ID=22202696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893105A NO893105L (no) 1987-12-02 1989-08-01 Acylderivater av hydroksypyrimidiner.

Country Status (26)

Country Link
EP (1) EP0319170B1 (ja)
JP (1) JPH0725740B2 (ja)
KR (1) KR910000415B1 (ja)
CN (1) CN1033379A (ja)
AT (1) ATE86983T1 (ja)
AU (1) AU609547B2 (ja)
CA (1) CA1336516C (ja)
DD (1) DD277275A5 (ja)
DE (1) DE3879410T2 (ja)
DK (1) DK671188A (ja)
EG (1) EG19003A (ja)
ES (1) ES2053769T3 (ja)
FI (1) FI893648A0 (ja)
HU (1) HU206203B (ja)
IE (1) IE63456B1 (ja)
IL (1) IL88512A0 (ja)
MX (1) MX14001A (ja)
MY (1) MY103499A (ja)
NO (1) NO893105L (ja)
NZ (1) NZ227163A (ja)
PL (1) PL158165B1 (ja)
PT (1) PT89124B (ja)
RU (1) RU2036909C1 (ja)
WO (1) WO1989005295A1 (ja)
YU (1) YU47013B (ja)
ZA (1) ZA888969B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5419323A (en) * 1988-12-21 1995-05-30 Massachusetts Institute Of Technology Method for laser induced fluorescence of tissue
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
KR20170057191A (ko) * 2017-05-04 2017-05-24 김점식 유압을 이용한 전기 자동차 구동장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) * 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines

Also Published As

Publication number Publication date
AU2647088A (en) 1989-06-08
DD277275A5 (de) 1990-03-28
DK671188D0 (da) 1988-12-01
CN1033379A (zh) 1989-06-14
DE3879410D1 (de) 1993-04-22
JPH0725740B2 (ja) 1995-03-22
MX14001A (es) 1993-06-01
NZ227163A (en) 1990-11-27
YU217988A (en) 1990-10-31
ATE86983T1 (de) 1993-04-15
NO893105D0 (no) 1989-08-01
PL276122A1 (en) 1989-06-12
PT89124A (pt) 1988-12-01
EP0319170B1 (en) 1993-03-17
IL88512A0 (en) 1989-06-30
KR890009890A (ko) 1989-08-04
IE883598L (en) 1989-06-02
YU47013B (sh) 1994-11-15
WO1989005295A1 (en) 1989-06-15
HU894552D0 (en) 1990-11-28
ES2053769T3 (es) 1994-08-01
ZA888969B (en) 1990-07-25
EG19003A (en) 1994-06-30
IE63456B1 (en) 1995-04-19
JPH01250364A (ja) 1989-10-05
PT89124B (pt) 1993-04-30
EP0319170A2 (en) 1989-06-07
EP0319170A3 (en) 1990-08-01
FI893648A0 (fi) 1989-08-01
DK671188A (da) 1989-07-28
HU206203B (en) 1992-09-28
AU609547B2 (en) 1991-05-02
RU2036909C1 (ru) 1995-06-09
DE3879410T2 (de) 1993-06-24
MY103499A (en) 1993-06-30
KR910000415B1 (ko) 1991-01-25
PL158165B1 (pl) 1992-08-31
CA1336516C (en) 1995-08-01
HUT55003A (en) 1991-04-29

Similar Documents

Publication Publication Date Title
ES2000734A6 (es) Un procedimiento para la preparacion de pirimidinas
DE69730156D1 (de) 5-Pyrimidinyl-4-yl-imidazole derivatives useful for the treatment of CSBP/RK/p38 mediated diseases
DE3855501D1 (de) Chinolin-derivate als antagonisten von leukotrien d 4?
ATE155143T1 (de) 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
FI954718A (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
DE69214397D1 (de) 2-Substituierte Indane-2-Carboxyalkyl-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
NO891470L (no) Fremgangsmaate for fremstilling av nye substituerte azetidinoner.
DE59310146D1 (de) Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre Verwendung als Arzneimittel
DE69004081D1 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
NO893105L (no) Acylderivater av hydroksypyrimidiner.
NO993915D0 (no) Substituerte (1,3-bis(cycloheksylmetyl)-1,2,3,6-tetrahydro-2,6-diokso-9H-pyrin-8-yl)fenylderivater, fremstilling derav og anvendelse for behandling av inflamatoriske tilstander og imunforstyrrelser
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DK23289D0 (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
ATE67992T1 (de) In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften.
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
NO870891L (no) FremgangsmŸte ved fremstilling av 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.
RU92016440A (ru) Производные гидрокси- и алкоксипиридинов
TH10636EX (th) การควบคุมศัตรู
SE8300624L (sv) Foreningen 4-amino-6-(cyklohexylamino)-5-(formylamino)-2-(metyltio)-pyrimidin som mellanprodukt vid framstellning av 9-cyklohexyl-2-alkoxi-9h-adeninderivat
ATE89820T1 (de) 4-amino-3-acylchinolin-derivate, und ihre verwendung als inhibitioren der magensekretion.
ES2016857B3 (es) Derivados de 4 - feniltiazol.
IT8302106A0 (it) Lozione per la cura delle alopecie